TRIM44 and neurodegenerative disease: In sum, based on the cytotoxicity cellular data and mitochondrial functional parameters analyzed, MC4 and MC7.2 emerged as potential drug candidates with a potential therapeutic application in mitochondrial oxidative stress-related diseases, particularly in hepatic and neurodegenerative diseases, presenting a better safety profile than the two quinone-based mitochondria-targeted molecules used for comparison.